Lung mass epidemiology and demographics

Jump to navigation Jump to search

Lung Mass Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Causes

Differentiating Lung Mass from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Diagnosis

Diagnostic Study of Choice

Evaluation of Lung Mass

Imaging of Lung Mass

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Lung mass epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lung mass epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lung mass epidemiology and demographics

CDC on Lung mass epidemiology and demographics

Lung mass epidemiology and demographics in the news

Blogs on Lung mass epidemiology and demographics

Directions to Hospitals Treating bone or soft tissue mass

Risk calculators and risk factors for Lung mass epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

The incidence rate of lung masses is approximately 58 per 100 000 individuals in the United States. The incidence of lung masses increases with age; the median age at diagnosis is between 25 to 70 years. Males are more commonly affected with lung masses than females. The male to female ratio is approximately 2 to 1. There is no racial predilection for lung masses.

Epidemiology and Demographics

Incidence

  • The incidence rate of malignant lung mass is approximately 58 per 100 000 individuals in the United States
  • The incidence rate of lung mass increases with age, tobacco use, and prior cancer

Prevalence

  • The prevalence of malignancy among lung mass ranges between 0.2% to 50%

Age

  • The median age at diagnosis for malignant lung mass is between 55 to 70 years.
  • The median age at diagnosis for benign lung mass is between 20 to 50 years.

Gender

  • Males are more commonly affected with lung mass than females. The male to female ratio is approximately 2 to 1.

Ethnicity

  • There is no racial predilection of lung mass

References